OPHTHALMOLOGY CASE STUDY
Complex Global Imaging Study in Pediatric Population
Anti-VEGF treatment via intravitreal injection has the potential to offer improved outcomes in the high-risk, vulnerable premature newborn population with ROP.
RESPIRATORY CASE STUDY
Centralized Spirometry Clinical Trial Endpoints
MERIT’s centralized spirometry services laid the foundation for this successful multi-study COPD development program.
ONCOLOGY SOLUTIONS
Collect and Hold Services
MERIT’s Collect and Hold services are ideal for early phase clinical trials in which there is a need to collect longitudinal imaging data, or where centralized imaging review may be incorporated at a later point in time.
BCVA SOLUTIONS
BCVA Services
MERIT offers comprehensive training, certification, and management of study BCVA activities as well as centralized data review of BCVA source documents.
We have substantial medical expertise in specialized therapeutic areas:
MERIT is your clinical endpoint expert. We partner with CROs, pharmaceutical, and biotech companies to deliver reliable endpoint services in global clinical trials. Together our work advances and accelerates the improvement of therapeutic options for patients worldwide.
Stay up to date on the latest MERIT news and content.
Most brain cancer diagnoses in the United States are glioma, and MERIT’s webinar explored the challenges and potential solutions for assessing these tumors. New therapies are being studied through clinical trials, many of which use response criteria such as Response Assessment in Neuro-Oncology (RANO). This...
Idiopathic Pulmonary Fibrosis (IPF) is the most common type of PF, and its prevalence is on the rise globally. Numerous Phase 2 and Phase 2b/3 trials are underway for the development of new IPF treatments. ...
Discover 4 reasons to partner with a clinical endpoint expert for your next respiratory trial....
Learn five facts about the current state of clinical trials including details about trial costs, enrollment issues, and the difficulty and complexity of today's studies....
Given that the relative survival rate of patients diagnosed with metastatic lung cancer is low, and that traditional chemotherapy and surgery are of limited efficacy, ADCs represent a potentially important treatment option....
MERIT provided fast, accurate reads to support the quick turnaround times of a biotech's retrospective review of an early phase Glioma study. ...
MERIT was engaged mid-study to supply the high-quality imaging data and expertise needed to keep a Phase II glioblastoma study on track. Learn how this resulted in a significant cost savings for the Sponsor....
Anti-VEGF treatment via intravitreal injection has the potential to offer improved outcomes in the high-risk, vulnerable premature newborn population with ROP. Learn more in our case study. ...
Learn how high-quality retinal images were key to this pilot study’s success and formed the basis for testing an AI algorithm....
Learn how MERIT’s imaging expertise and proprietary software play a vital role in gene therapy clinical trials. We leverage our experience supporting 29 gene therapy clinical trials, providing valuable knowledge of specialized modalities...
MERIT’s Imaging Expertise and Proprietary Software Perform a Crucial Role in Global Phase III Wet AMD Study....
MERIT’s spirometry and MBPC expertise form the cornerstone for successful Phase III bioequivalence study for generic asthma treatment....
MERIT’s spirometry expertise and quality overreads lay the foundation for successful multi-study COPD drug development program....
